CVS Health News

HSBC Downgrades CVS Health to Hold From Buy, Adjusts Price Target to $62 From $91

MT NewswiresMay 3 17:28

CVS Health Analyst Ratings

BenzingaMay 3 00:04

Barclays: Maintaining the CVS Health (CVS.US) rating, adjusted from a shareholding wait-and-see rating to a shareholding wait-and-see rating, and the target price was adjusted from $78.00 to $63.00.

Zhitong FinanceMay 2 22:51

CVS Health (CVS) Receives a Rating Update From a Top Analyst

TipRanksMay 2 20:10

Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Cross Country Healthcare (CCRN) and CVS Health (CVS)

TipRanksMay 2 20:03

RBC Cuts Price Target on CVS Health to $68 From $84 Amid Reduced Guidance, Keeps Outperform Rating

MT NewswiresMay 2 18:39

Truist Securities Adjusts Price Target on CVS Health to $66 From $90

MT NewswiresMay 2 18:34

RBC Capital Remains a Buy on CVS Health (CVS)

TipRanksMay 2 18:34

CVS Health Hold Rating Justified by Guidance Reduction and Uncertain Cost Trends

TipRanksMay 2 17:19

CVS Health Analyst Ratings

BenzingaMay 2 01:52

Cantor Fitzgerald Downgrades CVS Health to Neutral, Lowers Price Target to $58

BenzingaMay 2 01:54

CVS Health Downgraded to Market Perform Amid MA Recovery Uncertainties and Margin Challenges

TipRanksMay 2 00:55

Buy Rating Maintained for CVS Health Amidst Short-Term Challenges With Long-Term Growth Outlook

TipRanksMay 1 21:55

UBS Adjusts CVS Health Price Target to $85 From $90, Maintains Buy Rating

MT NewswiresApr 29 21:52

Morgan Stanley Cuts Price Target on CVS Health to $85 From $92

MT NewswiresApr 26 23:43

Wells Fargo Sticks to Its Hold Rating for CVS Health (CVS)

TipRanksApr 15 18:06

CVS Health Analyst Ratings

BenzingaApr 10 21:50

CVS Health Analyst Ratings

BenzingaApr 8 20:30

Wells Fargo Remains a Hold on CVS Health (CVS)

TipRanksApr 8 18:17

CVS Health Analyst Ratings

BenzingaApr 4 22:00